benzyl (1-hydroxypropan-2-yl)carbamate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: benzyl (1-hydroxypropan-2-yl)carbamate
• 英文别名: benzyl (2-hydroxy-1-methylethyl)-carbamate；Benzyl (2-hydroxy-1-methylethyl)carbamate；benzyl N-(1-hydroxypropan-2-yl)carbamate
• 化学式: C₁₁H₁₅NO₃
• 分子量: 209.245
• InChiKey: AFPHMHSLDRPUSM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  benzyl (1-hydroxypropan-2-yl)carbamate 在 磺酰氯 、 偶氮二甲酸二异丙酯 、 乙酸酐 、 三苯基膦 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 C₁₂H₁₈N₂O₃S
  参考文献：
  名称：

  Novel diamide insecticides: Sulfoximines, sulfonimidamides and other new sulfonimidoyl derivatives

  摘要：

  Novel insecticidal anthranilamides with elaborated sulfur-containing groups are described. The synthesis of compounds with functional groups such as sulfoximines and scarcely reported groups such as sulfonimidoyl hydrazides and hydroxylamides, their in vitro and in vivo biological activity as well as their physical properties are reported. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.03.106
• 作为产物：
  描述：

  N-Cbz-alaninal 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 生成 benzyl (1-hydroxypropan-2-yl)carbamate
  参考文献：
  名称：

  A rapid and efficient one-pot method for the reduction of N-protected α-amino acids to chiral α-amino aldehydes using CDI/DIBAL-H

  摘要：

  N-保护的α-氨基酸可以通过使用CDI激活后再用DIBAL-H还原，在一个步骤中轻松直接转化为手性α-氨基醛。

  DOI：

  10.1039/c5ob01838b

文献信息

• Highly efficient and practical aerobic oxidation of alcohols by inorganic-ligand supported copper catalysis
  作者：Zheyu Wei、Shi Ru、Qixin Zhao、Han Yu、Gang Zhang、Yongge Wei

  DOI：10.1039/c9gc01248f

  日期：——

  The oxidation of alcohols to aldehydes or ketones is a highly relevant conversion for the pharmaceutical and fine-chemical industries, and for biomass conversion, and is commonly performed using stoichiometric amounts of highly hazardous oxidants. The aerobic oxidation of alcohols with transition metal complex catalysts previously required complicated organic ligands and/or nitroxyl radicals as co-catalysts

  醇氧化为醛或酮对于制药和精细化学工业以及生物质转化而言是高度相关的转化，并且通常使用化学计量的高度危险的氧化剂进行。先前使用过渡金属络合物催化剂对醇进行好氧氧化需要复杂的有机配体和/或硝酰基自由基作为助催化剂。在这里，我们报告了一种高效且环保的方法，可使用无机配体负载的铜催化剂1（NH 4）4 [CuMo 6 O 18（OH）6 ]和O 2（1 atm ）来促进醇的需氧氧化）作为唯一的氧化剂。催化剂1它是由廉价且普遍使用的（NH 4）6 Mo 7 O 24 ·4H 2 O和CuSO 4直接合成的，CuSO 4由纯的无机骨架组成，该骨架由中心的Cu II核构建而成，并由六个Mo VI O 6无机支架支撑。铜催化剂1在醇的催化氧化中对多种底物表现出优异的选择性和活性，并且可以避免使用有毒的氧化剂，硝酰基自由基以及潜在的对空气/湿气敏感的复杂的有机配体，而这些配体是不可商购的。由于其坚固的无机骨
• PANTOTHENAMIDE ANALOGUES
  申请人：MMV Medicines for Malaria Venture

  公开号：EP3674288A1

  公开（公告）日：2020-07-01

  The present invention provides compounds that have antimalarial activity. More in particular, the present invention provides novel compounds that are analogues of pantothenamides. The pantothenamide analogues of this invention have particularly low IC50 values against the asexual blood stages and gametocytes of malaria parasites. Furthermore, the pantothenamide analogues of this invention are characterized by low hepatic metabolism. Therefore, pantothenamide analogues of the invention are particularly suitable for use in therapeutic and/or prophylactic treatment of protozoan infections in a human or animal subject in need thereof. The invention further provides pharmaceutical formulations comprising the pantothenamide analogues as well as the therapeutic and/or prophylactic uses of the pantothenamide analogues and pharmaceutical formulations comprising them.

  本发明提供具有抗疟疾活性的化合物。更具体地说，本发明提供了类泛酰胺的新化合物。本发明的泛酰胺类似物对疟疾寄生虫的无性血液阶段和配子体具有特别低的IC50值。此外，本发明的泛酰胺类似物具有低肝代谢特性。因此，本发明的泛酰胺类似物特别适用于用于治疗和/或预防人类或动物主体中原虫感染。本发明还提供包含泛酰胺类似物的药物配方，以及泛酰胺类似物的治疗和/或预防用途以及包含它们的药物配方。
• Amino Aldehydes Revisited
  作者：Luuk Mestrom、Paula Bracco、Ulf Hanefeld

  DOI：10.1002/ejoc.201701213

  日期：2017.12.22

  The enzymatic oxidation of amino alcohols was studied to address the long-standing problem of product stability. Amino aldehydes, the much sought after and unstable compounds, can be generated under mild conditions when they are immediately protected. Utilizing a range of alcohol dehydrogenases (ADHs) and semicarbazide as scavenger, the enantioselective synthesis of protected amino aldehydes is possible

  研究氨基醇的酶促氧化以解决长期存在的产品稳定性问题。氨基醛是备受追捧的不稳定化合物，当它们立即受到保护时，可以在温和条件下生成。利用一系列醇脱氢酶 (ADH) 和氨基脲作为清除剂，可以对受保护的氨基醛进行对映选择性合成。来自氧化葡糖杆菌 (GoGDH) 的甘油脱氢酶显示出优异的对映选择性，但底物范围有限，而马肝 ADH 催化广泛的转化，但对映选择性较低。
• Thiazolidine and oxazolidine derivatives, their preparation and their
  申请人：Sankyo Company, Limited

  公开号：US05578620A1

  公开（公告）日：1996-11-26

  Compounds of formula (I): ##STR1## and salts, esters and solyates thereof and pro-drugs therefor are useful for the treatment and/or prophylaxis of a variety of disorders, including one or more of: hyperlipemia, hyperglycemia, obesity, glucose tolerance insufficiency, insulin resistance and diabetic complications.

  公式（I）的化合物：##STR1##及其盐、酯和溶剂化合物以及其前体药物对于治疗和/或预防多种疾病非常有用，包括但不限于：高脂血症、高血糖、肥胖、葡萄糖耐量不足、胰岛素抵抗和糖尿病并发症。
• NOVEL HYDROXAMIC ACID DERIVATIVES
  申请人：Daiichi Fine Chemical Co., Ltd.

  公开号：EP1179529A1

  公开（公告）日：2002-02-13

  Disclosed are compounds which have not only potent metalloproteinase-inhibiting activity but also amazingly excellent bioavailability and biological activity in vivo, including the property of being well absorbed via oral routes, thereby serving as useful pharmaceuticals, intermediates and processes for the production thereof. The disclosed compounds of the formula (I): wherein R1 is hydrogen, or a hydroxy-protecting group; R2 is hydrogen, or an amino-protecting group; R3, R7, and R8, which may be identical or different, are each independently hydrogen, hydroxy, unsubstituted or optionally substituted (C1-C6) alkyl, or unsubstituted or optionally substituted aryl-(C1-C6) alkyl; R4 is unsubstituted or optionally substituted (C1-C6) alkyl, or unsubstituted or optionally substituted aryl-(C1-C6) alkyl; R5 is hydrogen, unsubstituted or optionally substituted alkyl, unsubstituted or optionally substituted aralkyl, or a carboxy-protecting group; R6 is hydrogen, hydroxy, amino, and a group of the formula: -X-Y wherein X is oxygen, (C1-C6) alkylene or phenylene, Y is a group of the formula: -A-B or -B, wherein A is (C1-C6) alkylene, imino, and (C1-C6) alkyleneimino, and B is hydrogen, amino, amidino, sulfonyl, acylimidoyl, unsubstituted or optionally substituted imidazolyl, unprotected or optionally protected bis(phosphono)methyl or unprotected or optionally protected bis(phosphono)hydroxymethyl; or salts thereof are useful for pharmaceutical and/or veterinary compositions, particularly as metalloproteinase inhibitors which inhibit matrix metalloproteinases or tumor necrosis factor-α-converting enzymes (TNF-α convertases).

  本公开的化合物不仅具有强大的金属蛋白酶抑制活性，而且在体内具有出色的生物利用度和生物活性，包括经口途径吸收良好的特性，因此可用作有用的药物、中间体和生产过程。公开的化合物的结构式（I）如下：其中R1是氢或羟基保护基；R2是氢或氨基保护基；R3、R7和R8可以相同也可以不同，分别独立地是氢、羟基、未取代或可选择取代的（C1-C6）烷基，或未取代或可选择取代的芳基-（C1-C6）烷基；R4是未取代或可选择取代的（C1-C6）烷基，或未取代或可选择取代的芳基-（C1-C6）烷基；R5是氢、未取代或可选择取代的烷基、未取代或可选择取代的芳基烷基，或羧基保护基；R6是氢、羟基、氨基，以及下式的基团：-X-Y，其中X是氧、（C1-C6）烷基或苯基，Y是下式的基团：-A-B或-B，其中A是（C1-C6）烷基、亚胺基和（C1-C6）烷基亚胺基，B是氢、氨基、酰胺基、磺酰基、乙酰亚胺基，未取代或可选择取代的咪唑基，未保护或可选择保护的双（膦酸甲基）或未保护或可选择保护的双（膦酸羟甲基）；或其盐在制药和/或兽医组合物中具有用途，尤其作为抑制基质金属蛋白酶或肿瘤坏死因子-α转化酶（TNF-α转化酶）的金属蛋白酶抑制剂。